Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Traders Are Talking About Chevron, Adobe, Petrobras, and More

Page 1 of 2

After being range-bound for the last few weeks, crude promises to be a little bit more volatile in the near-term following today’s release of the EIA inventory numbers and the September 26-28 Russia/OPEC meeting.

Given the catalysts ahead, it’s not surprising that traders are talking about energy stocks today. In this article, we’ll dig a little deeper into the events causing Clovis Oncology Inc (NASDAQ:CLVS), Adobe Systems Incorporated (NASDAQ:ADBE), Chevron Corporation (NYSE:CVX), Eni SpA (ADR) (NYSE:E), and Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR) to be in the spotlight and use the latest 13F data to see what hedge funds think of each stock.

Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

oil, rig, well, gas, oilman, job, russia, fuel, sunrise, power, business, controls, yellow, pump, jack, repairman, male, helmet, orange, drilling, sun, engineer, black, worker,

maradon 333/Shutterstock.com

Clovis Oncology Inc (NASDAQ:CLVS) is in the spotlight after the biotech surged by 12% on Tuesday on strong volume. Although no fundamental news drove Tuesday’s bullish price action, the stock has increased before on takeover speculation and likely did so yesterday. Analysts and writers have previously speculated that Clovis might be interesting to companies such as Gilead Sciences, Inc. (NASDAQ:GILD), among others, due to rucaparib’s potential (along with the other drug candidates in Clovis’ pipeline). Given the historical poor performance of buying takeover rumor stocks, there is no guarantee that the bullish price action in Clovis will continue, or end up paying off. Mitchell Blutt‘s Consonance Capital Management initiated a new position of over 2.9 million shares in Clovis Oncology Inc (NASDAQ:CLVS) in the second quarter.

Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Trade (NASDAQ:CLVS) Now!

Adobe Systems Incorporated (NASDAQ:ADBE) is 6% in the green after the software company reported better-than-expected results for its fiscal third quarter. For the period, Adobe earned $0.75 per share, versus estimates of $0.73, while revenue came in at $1.46 billion for the three months, up by 19.7% year-over-year, and $10 million ahead of the consensus. Guidance was also strong, with Adobe’s management expecting fiscal year 2016 adjusted EPS of $2.94-to-$3.00 on revenue of $5.8 billion-to-$5.85 billion. 58 funds had a long position in Adobe Systems Incorporated (NASDAQ:ADBE) at the end of the second quarter, down by five funds from the end of the first quarter.

Follow Adobe Systems Inc (NASDAQ:ADBE)
Trade (NASDAQ:ADBE) Now!

On the next page, we’ll examine why Chevron, Eni SpA, and Petroleo Brasileiro SA Petrobras are in the spotlight.

Page 1 of 2
Loading Comments...